IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 76 filers reported holding IMMUNE DESIGN CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $95,000 | -24.0% | 27,500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $125,000 | -52.7% | 27,500 | -65.6% | 0.00% | -62.5% |
Q1 2018 | $264,000 | -59.9% | 80,000 | -52.7% | 0.01% | -52.9% |
Q4 2017 | $659,000 | +93.8% | 169,034 | +238.1% | 0.02% | +30.8% |
Q1 2017 | $340,000 | -38.2% | 50,000 | -50.0% | 0.01% | -51.9% |
Q4 2016 | $550,000 | – | 100,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,236,394 | $5,626,000 | 8.66% |
Versant Venture Management, LLC | 2,208,210 | $10,047,356,000 | 3.14% |
EcoR1 Capital, LLC | 4,437,600 | $20,191,000 | 1.92% |
BVF INC/IL | 4,158,353 | $18,921,000 | 1.85% |
Abingworth LLP | 352,300 | $1,621,000 | 0.93% |
DAFNA Capital Management LLC | 328,500 | $1,495,000 | 0.70% |
Bain Capital Public Equity Management, LLC | 1,221,368 | $5,557,000 | 0.38% |
Portolan Capital Management | 444,875 | $2,024,000 | 0.21% |
Telemetry Investments, L.L.C. | 113,500 | $516,000 | 0.20% |
C M BIDWELL & ASSOCIATES LTD | 13,055 | $59,000 | 0.06% |